Most Recent
ANZ Bank executives briefly considered relaunching and repricing a botched $2.5 billion equity capital raising at the heart of two groundbreaking enforcement actions, and the decision by the share placement's underwriters to instead pick up a $790 million shortfall deprived investors of lower priced shares, a court has been told.
The Commonwealth Bank has been hit with a lawsuit by a former general manager who claims his retrenchment in 2013 violated the whistleblower protections under the Corporations Act.
A case simultaneously challenging IP Australia's decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product companies has been withdrawn, a court has heard.
An argument over the admissibility of an expert report produced by the Australian Securities and Investments Commission in its insurance churn case against AMP was sidestepped Monday, with a judge proposing experts from both sides instead file a joint report in the case.
An appeals court has reimposed penalties against the Construction, Forestry, Maritime, Mining and Energy Union, its NSW branch and nine officials for unlawful industrial action at Barangaroo, but dropped the total fine from $2.5 million to $1.7 million.
The US International Trade Commission has opened an investigation into alleged patent infringement by solar companies JinkoSolar, LONGi Solar and REC Group, after Korean solar company Hanwha Q CELLS filed two related proceedings in Australian court alleging the companies are infringing its solar technology.
Bega Cheese has presuaded a court to allow a partner from Addisons Lawyers to access select confidential documents, expanding the confidentiality regime at the heart of its dispute with Fonterra Brands over an allegedly violated trade mark licence agreement.
A judge has scheduled a two-day hearing to hear a dispute between investment group Caason Investments, a lead applicant in a shareholder class action against defunct laser technology company Arasor that settled last year for $19.25 million, and Singapore-based litigation funder International Litigation Partners over personal costs allegedly owed to the investment group under a "secret" side agreement.
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals' patent for its insomnia drug Circadin is invalid and should be revoked.
Litigation funder Litigation Capital Management will snap up 30 percent of a confidential settlement amount that KPMG has fought to keep under wraps in a shareholder class action over a failed $830 million hostile takeover bid of mining firm Discovery Metals.